Geospiza, NuGen to Co-market Next-gen Sequencing Workflow Products | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Geospiza announced today a co-marketing deal with NuGen Technologies for the development of a next-generation sequencing workflow to accelerate discoveries for large disease research studies.

Financial and other terms of the deal were not disclosed.

Based in Seattle, Geospiza develops software for genetic analysis. NuGen, based in San Carlos, Calif., develops amplification and labeling systems for genomic research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.